litlas
ログインアカウント作成

Erik Stomrud

2007–2026 年に発表

169
論文数
25,326
被引用数
78
h 指数
152
i10 指数

被引用数

Erik Stomrud の年別被引用数1988 年: 被引用 6 件2001 年: 被引用 3 件2008 年: 被引用 4 件2009 年: 被引用 10 件2010 年: 被引用 24 件2011 年: 被引用 23 件2012 年: 被引用 13 件2013 年: 被引用 11 件2014 年: 被引用 18 件2015 年: 被引用 7 件2016 年: 被引用 31 件2017 年: 被引用 67 件2018 年: 被引用 122 件2019 年: 被引用 394 件2020 年: 被引用 858 件2021 年: 被引用 1,463 件2022 年: 被引用 1,751 件2023 年: 被引用 1,661 件2024 年: 被引用 3,145 件2025 年: 被引用 2,281 件2026 年: 被引用 103 件1989〜2000 年は被引用が無いため表示していません2002〜2007 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,729 件、この内訳の 21.5%イギリス: 引用元論文 1,290 件、この内訳の 10.2%スウェーデン: 引用元論文 1,160 件、この内訳の 9.2%中国: 引用元論文 984 件、この内訳の 7.8%ドイツ: 引用元論文 646 件、この内訳の 5.1%スペイン: 引用元論文 514 件、この内訳の 4.1%オランダ: 引用元論文 513 件、この内訳の 4%カナダ: 引用元論文 482 件、この内訳の 3.8%イタリア: 引用元論文 438 件、この内訳の 3.4%フランス: 引用元論文 428 件、この内訳の 3.4%オーストラリア: 引用元論文 353 件、この内訳の 2.8%スイス: 引用元論文 302 件、この内訳の 2.4%
0%21.5%その他 22.3%

機関

分野

  • Medicine71.7%
  • Neuroscience13.4%
  • Biochemistry, Genetics and Molecular Biology9%
  • Computer Science0.9%
  • Psychology0.7%
  • Engineering0.7%
  • その他3.6%

トピック

  • Alzheimer's disease research and treatments19.8%
  • Dementia and Cognitive Impairment Research17%
  • Functional Brain Connectivity Studies3.7%
  • Neuroinflammation and Neurodegeneration Mechanisms3.1%
  • Parkinson's Disease Mechanisms and Treatments2.4%
  • Neurological Disease Mechanisms and Treatments2.3%
  • その他51.7%

共著者

全論文

検索で開く
  1. Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders

    著者: Sebastian Palmqvist, Shorena Janelidze, Yakeel T. Quiroz, Henrik Zetterberg, Francisco Lopera, Erik Stomrud, Yi Su, Yinghua Chen, Geidy E. Serrano, Antoine Leuzy, Niklas Mattsson, Olof Strandberg, Ruben Smith, Andrés Villegas, Diego Sepúlveda‐Falla, Xiyun Chai, Nicholas K. Proctor, Thomas G. Beach, Kaj Blennow, Jeffrey L. Dage, Eric M. Reiman, Oskar Hansson - JAMA 2020 被引用: 1,546

  2. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts

    著者: Thomas K. Karikari, Tharick A. Pascoal, Nicholas J. Ashton, Shorena Janelidze, Andréa Lessa Benedet, Juan Lantero‐Rodriguez, Mira Chamoun, Mélissa Savard, Min Su Kang, Joseph Therriault, Michael Schöll, Gassan Massarweh, Jean-Paul Soucy, Kina Höglund, Gunnar Brinkmalm, Niklas Mattsson, Sebastian Palmqvist, Serge Gauthier, Erik Stomrud, Henrik Zetterberg, Oskar Hansson, Pedro Rosa‐Neto, Kaj Blennow - The Lancet Neurology 2020 被引用: 1,360

  3. Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia

    著者: Shorena Janelidze, Niklas Mattsson, Sebastian Palmqvist, Ruben Smith, Thomas G. Beach, Geidy E. Serrano, Xiyun Chai, Nicholas K. Proctor, Udo Eichenlaub, Henrik Zetterberg, Kaj Blennow, Eric M. Reiman, Erik Stomrud, Jeffrey L. Dage, Oskar Hansson - Nature Medicine 2020 被引用: 1,271

  4. Highly accurate blood test for Alzheimer’s disease is similar or superior to clinical cerebrospinal fluid tests

    著者: Nicolas R Barthélemy, Gemma Salvadó, Suzanne E. Schindler, Yingxin He, Shorena Janelidze, Lyduine E. Collij, Benjamin Saef, Rachel L. Henson, Charles D. Chen, Brian A. Gordon, Yan Li, Renaud La Joie, Tammie L.S. Benzinger, John C. Morris, Niklas Mattsson, Sebastian Palmqvist, Rik Ossenkoppele, Gil D. Rabinovici, Erik Stomrud, Randall J. Bateman, Oskar Hansson - Nature Medicine 2024 被引用: 408

  5. Differential roles of Aβ42/40, p-tau231 and p-tau217 for Alzheimer’s trial selection and disease monitoring

    著者: Nicholas J. Ashton, Shorena Janelidze, Niklas Mattsson, Alexa Pichet Binette, Olof Strandberg, Wagner S. Brum, Thomas K. Karikari, Fernando González‐Ortiz, Guglielmo Di Molfetta, Francisco J. Meda, Erin M. Jonaitis, Rebecca L. Koscik, Karly Alex Cody, Tobey J. Betthauser, Yan Li, Eugeen Vanmechelen, Sebastian Palmqvist, Erik Stomrud, Randall J. Bateman, Henrik Zetterberg, Sterling C. Johnson, Kaj Blennow, Oskar Hansson - Nature Medicine 2022 被引用: 431

  6. Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline

    著者: Rik Ossenkoppele, Alexa Pichet Binette, Colin Groot, Ruben Smith, Olof Strandberg, Sebastian Palmqvist, Erik Stomrud, Pontus Tideman, Tomas Ohlsson, Jonas Jögi, Keith A. Johnson, Reisa A. Sperling, Vincent Doré, Colin L. Masters, Christopher C. Rowe, Denise Visser, Bart N. M. van Berckel, Wiesje M. van der Flier, Suzanne L. Baker, William J. Jagust, Heather J. Wiste, Ronald C. Petersen, Clifford R. Jack, Oskar Hansson - Nature Medicine 2022 被引用: 482

  7. Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer’s disease

    著者: Joana B Pereira, Shorena Janelidze, Ruben Smith, Niklas Mattsson, Sebastian Palmqvist, Charlotte E. Teunissen, Henrik Zetterberg, Erik Stomrud, Nicholas J. Ashton, Kaj Blennow, Oskar Hansson - Brain 2021 被引用: 587

  8. CSF biomarkers of Alzheimer's disease concord with amyloid‐β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts

    著者: Oskar Hansson, John Seibyl, Erik Stomrud, Henrik Zetterberg, John Q. Trojanowski, Tobias Bittner, Valeria Lifke, Veronika Corradini, Udo Eichenlaub, Richard Batrla, Katharina Buck, Katharina Zink, Christina Rabe, Kaj Blennow, Leslie M. Shaw, for the Swedish BioFINDER study group, Alzheimer's Disease Neuroimaging Initiative - Alzheimer s & Dementia 2018 被引用: 829

  9. Prediction of future Alzheimer’s disease dementia using plasma phospho-tau combined with other accessible measures

    著者: Sebastian Palmqvist, Pontus Tideman, Nicholas Cullen, Henrik Zetterberg, Kaj Blennow, the Alzheimer’s Disease Neuroimaging Initiative, Jeffrey L. Dage, Erik Stomrud, Shorena Janelidze, Niklas Mattsson, Oskar Hansson - Nature Medicine 2021 被引用: 534

  10. A multicentre validation study of the diagnostic value of plasma neurofilament light

    著者: Nicholas J. Ashton, Shorena Janelidze, Ahmad Al Khleifat, Antoine Leuzy, Emma L. van der Ende, Thomas K. Karikari, Andréa Lessa Benedet, Tharick A. Pascoal, Alberto Lleó, Lucilla Parnetti, Daniela Galimberti, Laura Bonanni, Andrea Pilotto, Alessandro Padovani, Jan Lycke, Lenka Novakova, Markus Axelsson, Latha Velayudhan, Gil D. Rabinovici, Bruce L. Miller, Carmine M. Pariante, Naghmeh Nikkheslat, Susan M. Resnick, Madhav Thambisetty, Michael Schöll, Gorka Fernández‐Eulate, Francisco J. Gil‐Bea, Adolfo López de Munaín, Ammar Al‐Chalabi, Pedro Rosa‐Neto, André Strydom, Per Svenningsson, Erik Stomrud, Alexander Santillo, Dag Aarsland, John C. van Swieten, Sebastian Palmqvist, Henrik Zetterberg, Kaj Blennow, Abdul Hye, Oskar Hansson - Nature Communications 2021 被引用: 555

  11. Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity

    著者: Sebastian Palmqvist, Michael Schöll, Olof Strandberg, Niklas Mattsson, Erik Stomrud, Henrik Zetterberg, Kaj Blennow, Susan Landau, William J. Jagust, Oskar Hansson - Nature Communications 2017 被引用: 947

  12. Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers

    著者: Niklas Mattsson, Gemma Salvadó, Nicholas J. Ashton, Pontus Tideman, Erik Stomrud, Henrik Zetterberg, Rik Ossenkoppele, Tobey J. Betthauser, Karly Alex Cody, Erin M. Jonaitis, Rebecca Langhough, Sebastian Palmqvist, Kaj Blennow, Shorena Janelidze, Sterling C. Johnson, Oskar Hansson - JAMA Neurology 2023 被引用: 295

  13. A two-step workflow based on plasma p-tau217 to screen for amyloid β positivity with further confirmatory testing only in uncertain cases

    著者: Wagner S. Brum, Nicholas Cullen, Shorena Janelidze, Nicholas J. Ashton, Eduardo R. Zimmer, Joseph Therriault, Andréa Lessa Benedet, Nesrine Rahmouni, Cécile Tissot, Jenna Stevenson, Stijn Servaes, Gallen Triana‐Baltzer, Hartmuth C. Kolb, Sebastian Palmqvist, Erik Stomrud, Pedro Rosa‐Neto, Kaj Blennow, Oskar Hansson - Nature Aging 2023 被引用: 241

  14. CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer’s disease

    著者: Kanta Horie, Gemma Salvadó, Nicolas R. Barthélemy, Shorena Janelidze, Yan Li, Yingxin He, Benjamin Saef, Charles D. Chen, Hong Jiang, Olof Strandberg, Alexa Pichet Binette, Sebastian Palmqvist, Chihiro Sato, Pallavi Sachdev, Akihiko Koyama, Brian A. Gordon, Tammie L.S. Benzinger, David M. Holtzman, John C. Morris, Niklas Mattsson, Erik Stomrud, Rik Ossenkoppele, Suzanne E. Schindler, Oskar Hansson, Randall J. Bateman - Nature Medicine 2023 被引用: 250

  15. Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care

    著者: Sebastian Palmqvist, Pontus Tideman, Niklas Mattsson, Suzanne E. Schindler, Ruben Smith, Rik Ossenkoppele, Susanna Calling, Tim West, Mark Monane, Philip B. Verghese, Joel B. Braunstein, Kaj Blennow, Shorena Janelidze, Erik Stomrud, Gemma Salvadó, Oskar Hansson - JAMA 2024 被引用: 327

  16. Associations of Plasma Phospho-Tau217 Levels With Tau Positron Emission Tomography in Early Alzheimer Disease

    著者: Shorena Janelidze, David Berron, Ruben Smith, Olof Strandberg, Nicholas K. Proctor, Jeffrey L. Dage, Erik Stomrud, Sebastian Palmqvist, Niklas Mattsson, Oskar Hansson - JAMA Neurology 2020 被引用: 374

  17. Confounding factors of Alzheimer's disease plasma biomarkers and their impact on clinical performance

    著者: Alexa Pichet Binette, Shorena Janelidze, Nicholas Cullen, Jeffrey L. Dage, Randall J. Bateman, Henrik Zetterberg, Kaj Blennow, Erik Stomrud, Niklas Mattsson, Oskar Hansson - Alzheimer s & Dementia 2022 被引用: 219

  18. Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease

    著者: Shorena Janelidze, Erik Stomrud, Ruben Smith, Sebastian Palmqvist, Niklas Mattsson, David Airey, Nicholas K. Proctor, Xiyun Chai, Sergey Shcherbinin, John R. Sims, Gallen Triana‐Baltzer, Clara Theunis, Randy Slemmon, Marc Mercken, Hartmuth C. Kolb, Jeffrey L. Dage, Oskar Hansson - Nature Communications 2020 被引用: 453

  19. CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer’s disease

    著者: Nicolas R. Barthélemy, Benjamin Saef, Yan Li, Brian A. Gordon, Yingxin He, Kanta Horie, Erik Stomrud, Gemma Salvadó, Shorena Janelidze, Chihiro Sato, Vitaliy Ovod, Rachel L. Henson, Anne M. Fagan, Tammie L.S. Benzinger, Chengjie Xiong, John C. Morris, Oskar Hansson, Randall J. Bateman, Suzanne E. Schindler - Nature Aging 2023 被引用: 151

  20. Longitudinal plasma p-tau217 is increased in early stages of Alzheimer’s disease

    著者: Niklas Mattsson, Shorena Janelidze, Sebastian Palmqvist, Nicholas Cullen, Anna L. Svenningsson, Olof Strandberg, David Mengel, Dominic M. Walsh, Erik Stomrud, Jeffrey L. Dage, Oskar Hansson - Brain 2020 被引用: 346

  21. Clinical effects of Lewy body pathology in cognitively impaired individuals

    著者: Corinne Quadalti, Sebastian Palmqvist, Sara Hall, Marcello Rossi, Angela Mammana, Shorena Janelidze, Sofia Dellavalle, Niklas Mattsson, Simone Baiardi, Erik Stomrud, Oskar Hansson, Piero Parchi - Nature Medicine 2023 被引用: 160

  22. Plasma β-amyloid in Alzheimer’s disease and vascular disease

    著者: Shorena Janelidze, Erik Stomrud, Sebastian Palmqvist, Henrik Zetterberg, Danielle van Westen, Andreas Jeromin, Linan Song, David Hanlon, Cristina A. Tan Hehir, David Baker, Kaj Blennow, Oskar Hansson - Scientific Reports 2016 被引用: 621

  23. Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer’s disease

    著者: Niklas Mattsson, Emelie Andersson, Shorena Janelidze, Rik Ossenkoppele, Philip S. Insel, Olof Strandberg, Henrik Zetterberg, Howard J. Rosen, Gil D. Rabinovici, Xiyun Chai, Kaj Blennow, Jeffrey L. Dage, Erik Stomrud, Ruben Smith, Sebastian Palmqvist, Oskar Hansson - Science Advances 2020 被引用: 374

  24. Cognitive effects of Lewy body pathology in clinically unimpaired individuals

    著者: Sebastian Palmqvist, Marcello Rossi, Sara Hall, Corinne Quadalti, Niklas Mattsson, Sofia Dellavalle, Pontus Tideman, Joana B. Pereira, Maria H Nilsson, Angela Mammana, Shorena Janelidze, Simone Baiardi, Erik Stomrud, Piero Parchi, Oskar Hansson - Nature Medicine 2023 被引用: 161